ResMed, Inc. (RMD)
252.33
+0.83
(+0.33%)
USD |
NYSE |
Dec 11, 15:34
ResMed Market Cap: 36.83B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 136.18B |
| Abbott Laboratories | 214.61B |
| Becton, Dickinson & Co. | 57.09B |
| Insulet Corp. | 20.69B |
| West Pharmaceutical Services, Inc. | 19.49B |
Market Cap Related Metrics
| PE Ratio | 25.82 |
| PS Ratio | 7.063 |
| PEG Ratio | 0.8744 |
| Price to Book Value | 6.017 |
| Price to Free Cash Flow | 21.14 |
| Price | 252.33 |
| Earnings Yield | 3.87% |
| PEGY Ratio | 0.8485 |
| Operating PE Ratio | 21.07 |
| Normalized PE Ratio | 25.73 |